Inclusion completed

A two-stage phase 1b study to investigate the pharmacokinetics, safety and tolerability of rituximab subcutaneus (SC) formulation in patients with follicular lymphoma (FL) as part of maintenance treatment

Cancer type: Lymphoma

Phase: I

Principal Investigator: Leppä Sirpa

Country: FI

Keywords: Finland

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT00930514?term=rituximab+sc&rank=3